METHYLPREDNISOLONE SODIUM SUCC J Code: J2920

Drug & Product Overview

HCPCS Descriptor Injection, methylprednisolone sodium succinate, up to 40 mg

HCPCS Added Date January 1, 1982

Manufacturer Multiple Manufacturers

Route of Administration Intramuscular, Intravenous

Generic Status HCPCS Discontinued

Dosage Type Single-Dose

Dosage Form Injection | Injection, Powder, For Solution | Injection, Powder, Lyophilized, For Solution

About METHYLPREDNISOLONE SODIUM SUCC

Methylprednisolone Sodium SUCC is a medication aligned to the HCPCS J Code: J2920 for billing, pricing, and reimbursement purposes in the United States. It is an Immunology drug administered via the intramuscular or intravenous routes and manufactured by multiple companies.

Manufacturers, reach out to us to add more information.

NDC Code Information

8 NDC packages are crosswalked to J2920. Package detail is available to logged-in subscribers.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
•••••-••••-•• Log in to view	METHYLPREDNISOLONE SODIUM SUCC
	METHYLPREDNISOLONE SODIUM SUCC
	METHYLPREDNISOLONE SODIUM SUCC
	METHYLPREDNISOLONE SODIUM SUCC

Login to view 8 NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

METHYLPREDNISOLONE SODIUM SUCC CPT Administration Codes

CPT Code	Description
96372	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intramuscular

Not on the CMS JW / JZ list

CMS does not include Methylprednisolone Sodium SUCC (J2920) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J2920. Wastage billing guide →

METHYLPREDNISOLONE SODIUM SUCC Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Acute exacerbations of multiple sclerosis All indications — pediatric (general) Allergic states Allergic states (asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, serum sickness, transfusion reactions) Allergic states — asthma uncontrolled by inhaled corticosteroids and long-acting bronchodilators Allergic states — pediatric asthma Asthma Asthma (pediatric, uncontrolled by inhaled corticosteroids and long-acting bronchodilators) Cerebral edema associated with primary or metastatic brain tumor, or craniotomy Dermatologic diseases Dermatologic diseases (bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme) Endocrine disorders Endocrine disorders (adrenocortical insufficiency, congenital adrenal hyperplasia, hypercalcemia associated with cancer, nonsuppurative thyroiditis) Endocrine disorders (primary or secondary adrenocortical insufficiency, congenital adrenal hyperplasia, hypercalcemia associated with cancer, nonsuppurative thyroiditis) Gastrointestinal diseases Gastrointestinal diseases (regional enteritis, ulcerative colitis) Hematologic disorders Hematologic disorders (acquired hemolytic anemia, Diamond-Blackfan anemia, idiopathic thrombocytopenic purpura, pure red cell aplasia, secondary thrombocytopenia) Hematologic disorders (autoimmune hemolytic anemia, Diamond-Blackfan anemia, idiopathic thrombocytopenic purpura, pure red cell aplasia, secondary thrombocytopenia) Leukemias and lymphomas Miscellaneous (trichinosis with neurologic or myocardial involvement, tuberculous meningitis with subarachnoid block) Miscellaneous (trichinosis with neurologic/myocardial involvement, tuberculous meningitis with subarachnoid block) Miscellaneous (trichinosis, tuberculous meningitis) Multiple indications — pediatric patients (general) Multiple sclerosis, acute exacerbations Neoplastic diseases (leukemias and lymphomas) Neoplastic diseases (leukemias, lymphomas) Nervous system disorders (cerebral edema, brain tumor/craniotomy) Ophthalmic diseases Ophthalmic diseases (sympathetic ophthalmia, uveitis, ocular inflammatory conditions) Renal diseases Renal diseases (idiopathic nephrotic syndrome, nephrotic syndrome due to lupus erythematosus) Renal diseases (nephrotic syndrome) Respiratory diseases Respiratory diseases (berylliosis, pulmonary tuberculosis, idiopathic eosinophilic pneumonias, sarcoidosis) Respiratory diseases (berylliosis, pulmonary tuberculosis, idiopathic eosinophilic pneumonias, symptomatic sarcoidosis) Rheumatic disorders Rheumatic disorders (acute gouty arthritis, acute rheumatic carditis, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, dermatomyositis, temporal arteritis, polymyositis, systemic lupus erythematosus) Rheumatic disorders (acute gouty arthritis, acute rheumatic carditis, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, dermatomyositis, temporal arteritis, polymyositis, systemic lupus erythematosus) Trichinosis with neurologic or myocardial involvement Tuberculous meningitis with subarachnoid block or impending block

Show all 41 conditions Show fewer

Drug Class

Corticosteroid Hormone Receptor Agonists [MoA]Corticosteroid [EPC]

Frequently Asked Questions

Is there an available Methylprednisolone Sodium Succ billing and coding guide?

We have not yet identified a manufacturer source of Methylprednisolone Sodium Succ billing and coding information.

Are there any available Methylprednisolone Sodium Succ patient assistance programs?

Our team did not identify a source for Methylprednisolone Sodium Succ patient assistance information. Please reach out to our team if you feel that this is a mistake.

Where can I find Methylprednisolone Sodium Succ prescribing information?

Our team is still working to identify a prescribing information source for METHYLPREDNISOLONE SODIUM SUCC

Where can I find Methylprednisolone Sodium Succ side effect information?

Our team has not yet identified a source of side effects information for METHYLPREDNISOLONE SODIUM SUCC. Please check back in a few weeks.

Does billing METHYLPREDNISOLONE SODIUM SUCC require JZ/JW wastage modifiers?

CMS does not include METHYLPREDNISOLONE SODIUM SUCC (J2920) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J2920. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.